Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Burn Degree Second: later-stage trial registry

1 of 1 indexed Burn Degree Second trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Burn Degree Second: 1 US clinical trial tracked, 1 recruiting.

Burn Degree Second is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is XenoTherapeutics, running 1 of these trials.

Enrollment posture brief

Registry condition burn-degree-second

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Burn Degree Second (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Burn Degree Second

Burn Degree Second lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Burn Degree Second on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Burn Degree Second is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

XenoTherapeutics 1 trials

Named interventions

Most-linked intervention names on Burn Degree Second records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Autograft(ing) Procedure
1 trials
Skin Xenotransplant Drug
1 trials

US sites by state

Facility locations filed on Burn Degree Second trials. A trial with sites in several states counts in each.

Maine 1 trials
Massachusetts 1 trials
Georgia 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Burn Degree Second page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Burn Degree Second trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • XenoTherapeutics sponsors the most Burn Degree Second trials on record, review their full trial history before evaluating a specific study. See XenoTherapeutics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Burn Degree Second condition card totals 1 registered trials; most-linked intervention Autograft(ing); top US site state Maine. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.